Nantahala Capital Management LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:39 pm Purchase |
2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,224,339 9.990% |
136,424 (+12.54%) |
Filing |
| 2024-12-20 4:32 pm Purchase |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,087,914 9.990% |
71,979 (+7.09%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,015,935 9.990% |
668,364 (+192.30%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 347,571 9.900% |
226,830 (+187.86%) |
Filing |
| 2023-02-14 4:52 pm Sale |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 120,742 8.000% |
-3,934 (-3.16%) |
Filing |
| 2022-02-14 08:35 am Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 124,676 8.000% |
124,676 (New Position) |
Filing |